摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-methylbut-2-en-1-yl phenyl carbonate | 138621-74-6

中文名称
——
中文别名
——
英文名称
3-methylbut-2-en-1-yl phenyl carbonate
英文别名
3-Methylbut-2-enyl phenyl carbonate
3-methylbut-2-en-1-yl phenyl carbonate化学式
CAS
138621-74-6
化学式
C12H14O3
mdl
——
分子量
206.241
InChiKey
GFWSUTMWGMNRLX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    289.0±23.0 °C(Predicted)
  • 密度:
    1.069±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-methylbut-2-en-1-yl phenyl carbonate 在 palladium diacetate 三苯基膦 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 以42%的产率得到((2-methylbut-3-en-2-yl)oxy)benzene
    参考文献:
    名称:
    Synthesis of allylic aryl ethers via palladium-catalyzed decarboxylation of allylic aryl carbonates
    摘要:
    Allylic aryl ethers are readily prepared in high yield by the palladium-catalyzed decarboxylation of allylic aryl carbonates.
    DOI:
    10.1016/0040-4039(91)80156-z
  • 作为产物:
    描述:
    氯甲酸苯酯异戊烯醇吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 以33%的产率得到3-methylbut-2-en-1-yl phenyl carbonate
    参考文献:
    名称:
    亲核 Fe 催化中的氧化还原活性三唑鎓衍生配体 - 反应性分布和区域选择性 O-烯丙基化的发展
    摘要:
    三唑鎓衍生的 N-杂环卡宾 (aNHC) 配体通过相应三唑鎓盐的去质子化很容易获得,被证明是各种烯丙基取代反应中的通用配体。相应的三唑鎓盐是由叠氮化物和炔烃通过 1,3-偶极环加成和 N-烷基化反应形成的。这些配体的独特性质是在其释放形式时是两性离子的,并作为强氧化还原活性 σ-供体配体。凭借这些特性,这些配体能够开发出前所未有的 Fe 催化的烯丙基碳酸酯区域选择性芳氧基化。
    DOI:
    10.1002/ejoc.201300902
点击查看最新优质反应信息

文献信息

  • Nickel-Catalyzed Reductive Allylation of Tertiary Alkyl Halides with Allylic Carbonates
    作者:Haifeng Chen、Xiao Jia、Yingying Yu、Qun Qian、Hegui Gong
    DOI:10.1002/anie.201705521
    日期:2017.10.9
    of all C(sp3) quaternary centers has been successfully achieved under Ni‐catalyzed cross‐electrophile coupling of allylic carbonates with unactivated tertiary alkyl halides. For allylic carbonates bearing C1 or C3 substituents, the reaction affords excellent regioselectivity through the addition of alkyl groups to the unsubstituted allylic carbon terminus. The allylic alkylation method also exhibits
    在烯丙基碳酸酯与未活化叔烷基卤化物的催化交叉亲电子偶联下,已成功实现了所有C(sp 3)季盐中心的构建。对于带有C1或C3取代基的烯丙基碳酸酯,该反应通过向未取代的烯丙基碳末端加成烷基而提供了优异的区域选择性。烯丙基烷基化方法还具有出色的官能团相容性,并提供具有高E 选择性的产品。
  • Multienzymatic Synthesis of γ‐Lactam Building Blocks from Unsaturated Esters and Hydroxylamine
    作者:Christina Jäger、Martin Nieger、Kari Rissanen、Jan Deska
    DOI:10.1002/ejoc.202300288
    日期:2023.10.16
    hydroxylamidation with an oxidase/peroxidase-induced ene-type cyclization. This methodology provides a mild and scalable access to N-heterocyclic building blocks from basic γ,δ-unsaturated esters and aqueous hydroxylamine, and its utility is illustrated by the formal total synthesis of the tetracyclic alkaloid cephalotaxine.
    N-羟基-γ-内酰胺是通过将脂肪酶催化的羟酰胺化与氧化酶/过氧化物酶诱导的烯型环化相结合的酶促序列来生产的。该方法提供了从碱性γ,δ-不饱和酯和羟胺中温和且可扩展地获得N-杂环结构单元的方法,其实用性通过四环生物碱头孢噻嗪的正式全合成得到了说明。
  • PROCESS FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANE COMPOUND AND ASYMMETRIC COPPER COMPLEX FOR USE IN THE SAME
    申请人:Sumitomo Chemical Company, Limited
    公开号:EP1674445A1
    公开(公告)日:2006-06-28
    A process for producing an optically active cyclopropane compound represented by the formula (4): wherein R3, R4, R5 and R6 are the same or different, and represent a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, and so on; and R7 represents a C1-6 alkyl group; and * represents an asymmetric carbon atom, which comprises reacting a prochiral olefin represented by the formula (2): wherein R3, R4, R5, and R6 are as described above, with a diazoacetic acid ester represented by the formula (3):         N2CHCO2R7     (3) wherein R7 is as defined above, in the presence of an asymmetric copper complex prepared from an optically active cycloalkylidenebisoxazoline compound represented by the formula (1): wherein R1 represents a hydrogen atom, a C1-6 alkyl group, and so on; R2 represents a C1-6 alkyl group and so on; and n represents an integer of 0 to 3; provided that, two R1s may be bonded each other together with the carbon atom to which they are bonded to form a ring; and * represents an asymmetric carbon atom, and a copper compound, is provided.
    一种生产由式(4)表示的光学活性环丙烷化合物的工艺: 其中 R3、R4、R5 和 R6 相同或不同,代表氢原子、卤素原子、取代或未取代的烷基等;R7 代表 C1-6 烷基;* 代表不对称碳原子、 其中包括使式 (2) 所代表的手性烯烃发生反应: 其中 R3、R4、R5 和 R6 如上所述,与式 (3) 所代表的重氮乙酸酯反应: N2CHCO2R7 (3) 其中 R7 如上定义,在由式(1)代表的光学活性环烷基亚双噁唑啉化合物制备的不对称络合物存在下: 其中,R1 代表氢原子、C1-6 烷基等;R2 代表 C1-6 烷基等;n 代表 0 至 3 的整数;条件是两个 R1 可与它们所键合的碳原子一起相互键合以形成环;* 代表不对称碳原子、 以及一种化合物。
  • METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANECARBOXYLATE COMPOUND
    申请人:Sumitomo Chemical Company, Limited
    公开号:EP1783111B1
    公开(公告)日:2015-04-08
  • Process for producing optically active cyclopropane compound and asymmetric copper complex for use in the same
    申请人:Itagaki Makoto
    公开号:US20070032659A1
    公开(公告)日:2007-02-08
    A process for producing an optically active cyclopropane compound represented by the formula (4): wherein R 3 , R 4 , R 5 and R 6 are the same or different, and represent a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, and so on; and R 7 represents a C1-6 alkyl group; and * represents an asymmetric carbon atom, which comprises reacting a prochiral olefin represented by the formula (2): wherein R 3 , R 4 , R 5 , and R 6 are as described above, with a diazoacetic acid ester represented by the formula (3): N 2 CHCO 2 R 7 (3) wherein R 7 is as defined above, in the presence of an asymmetric copper complex prepared from an optically active cycloalkylidenebisoxazoline compound represented by the formula (1): wherein R 1 represents a hydrogen atom, a C1-6 alkyl group, and so on; R 2 represents a C1-6 alkyl group and so on; and n represents an integer of 0 to 3; provided that, two R 1 s may be bonded each other together with the carbon atom to which they are bonded to form a ring; and * represents an asymmetric carbon atom, and a copper compound, is provided.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫